Skip to content
Drug recall · FDA · Published September 6, 2019

Teva Pharmaceuticals USA recalls Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30 count bottle, Rx only, Manufactured by:

Teva Pharmaceuticals USA recalls Matzim LA (Diltiaz: 240mg tablets due to a manufacturing deviation. This lot was not intended for commercial distribution. Consumers should contact the manufacturer for details.

🇺🇸 FDA recall #D-0131-2020DrugTeva Pharmaceuticals USA ›
Take action

Contact the company & request your remedy

Recalling firmTeva Pharmaceuticals USA400 Interpace Pkwy, N/A · Parsippany, NJ 07054-1120
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

Teva Pharmaceuticals USA is recalling Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30-count bottles because they were manufactured in a lot not intended for commercial distribution. This means the product may not meet quality standards and could pose risks to patients. Read more at govinfonow.com/recall/38021-teva-matzim-la-240mg-tablets-recall-gmp-deviation-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/38021-teva-matzim-la-240mg-tablets-recall-gmp-deviation-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-0131-2020

Cite this page

“Teva Matzim LA 240mg Tablets Recall: GMP Deviation Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38021-teva-matzim-la-240mg-tablets-recall-gmp-deviation-risk. Based on FDA recall #D-0131-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0131-2020%22&limit=1).

Why it’s dangerous

The recall is due to a GMP (Good Manufacturing Practice) deviation where the product was not intended for commercial distribution. This could mean the tablets do not meet quality standards and may not be safe for use.

Who’s affected

Patients prescribed Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30-count bottles by a healthcare provider are affected. Those who have the specific lot number (1344864A) are at risk.

How to tell if you have this one

Check for the product name Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30-count bottle. Look for the lot number 1344864A and expiration date 10/2020 on the packaging.

  • Brand
    Teva Pharmaceuticals USA
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Contact Manufacturer

    Reach out to Teva Pharmaceuticals USA for specific instructions on how to handle the recalled product.

✎ GovInfoNow

Questions people ask

Why is this product being recalled?

The product was manufactured in a lot not intended for commercial distribution, which is a GMP deviation.

What should I do if I have this product?

Contact Teva Pharmaceuticals USA for specific instructions on how to handle the recalled product.

Is there a risk of serious injury from this product?

The recall is due to a manufacturing deviation, but the official notice does not specify a risk of serious injury.

Take action

Contact Teva Pharmaceuticals USA

We’ve drafted a message you can send Teva Pharmaceuticals USA to request your refund or repair — edit it as you like.

Subject: Recall D-0131-2020 — Teva Pharmaceuticals USA Teva Pharmaceuticals USA

Hello,

I own a Teva Pharmaceuticals USA that is covered by recall D-0131-2020 from Teva Pharmaceuticals USA.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0131-2020 (September 6, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0131-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA